Androgenetic Alopecia vs. Telogen Effluvium: Key Differences

Androgenetic alopecia vs. telogen effluvium is a comparison between progressive hair thinning and a disturbance of the hair growth cycle that causes excessive shedding. Both can make the scalp more visible, but they do not necessarily require the same response. Before considering a hair transplant, the important question is whether the follicles are producing increasingly fine hairs, shedding more hairs than usual, or experiencing both processes together.

Quick Answer

Androgenetic alopecia and telogen effluvium are distinct hair loss conditions that can also occur simultaneously in the same individual. Androgenetic alopecia is a progressive genetic condition causing hair follicle miniaturization and gradual thinning in specific patterns. In contrast, telogen effluvium is a temporary disruption of the growth cycle caused by physical or emotional stress, resulting in widespread, excessive hair shedding without destroying the underlying follicles.

Androgenetic Alopecia vs. Telogen Effluvium: What Changes Beneath the Scalp?

In androgenetic alopecia, susceptible follicles gradually undergo miniaturisation. Over successive growth cycles, they produce hairs that are finer, shorter and less effective at covering the scalp. Someone may notice that their hairstyle no longer holds its shape or that their scalp shows through under bright light, even without a dramatic increase in hair on the brush.

In men, this often appears as recession at the temples and thinning around the crown. In women, a widening part and reduced density over the top of the scalp are common. These patterns offer clues, although appearance alone cannot confirm the diagnosis.

Telogen effluvium follows a different course. More follicles than usual move into the resting phase, and the affected hairs are subsequently shed. An illness, childbirth, surgery, substantial weight loss or another significant physical or emotional stressor may precede the change. The shedding often becomes noticeable two to four months later, which can make the connection difficult to recognise.

The loss usually affects the scalp more widely. Importantly, shedding a hair shaft does not mean that the follicle beneath the skin has been destroyed. In many cases, growth can recover as the disturbance resolves.

Editorial illustration contrasting pattern hair thinning and diffuse hair shedding with hair follicle motifs.

Can You Have Both Conditions at the Same Time?

Yes. A person can have underlying androgenetic alopecia and develop telogen effluvium as well. This is one reason the androgenetic alopecia vs. telogen effluvium distinction cannot be settled simply by counting shed hairs.

Consider someone whose hair has slowly lost volume over several years, followed by a sudden period of heavy shedding after an illness. The recent shedding may be temporary, while the earlier thinning reflects a continuing process. Even when the shedding improves, the underlying pattern loss may remain.

The British Association of Dermatologists’ guidance on telogen effluvium explains that the two conditions can occur together. It also notes that telogen effluvium lasting more than six months is considered chronic. “Temporary” therefore does not mean that every case resolves quickly or follows an identical timetable.

An assessment should examine the history, distribution of thinning and condition of the scalp. Magnified examination can help evaluate hair thickness and signs of miniaturisation. Where the history or findings suggest it, a clinician may investigate factors such as iron deficiency or thyroid disease. Testing should answer a clinical question rather than become a standard package for everyone.

What Does the Diagnosis Mean for a Hair Transplant?

When telogen effluvium is the main issue, transplanting additional follicles does not address the reason the existing hairs are shedding. The appropriate starting point is to investigate the cause and allow recovery to be assessed. Operating before that picture becomes clear can commit a limited donor reserve to an area whose appearance may still change.

Androgenetic alopecia requires a different discussion. Medical management may help preserve existing hair, and transplantation may be appropriate for a suitable candidate. However, surgery redistributes follicles; it does not stop the underlying hair-loss process. The design must account for future thinning and the capacity of the donor area.

A visible area of thinning tells us where the problem appears. It does not, by itself, tell us what should be done.

In The Hair Transplant Doctrine, I place this decision before technique selection and graft numbers. My earlier article on hair loss diagnosis before a hair transplant explores that starting point. Understanding the cause gives us a basis for deciding whether to treat, monitor or consider surgery—and for protecting the options a person may need later.

Frequently Asked Questions

What are the main clinical signs of androgenetic alopecia?

Androgenetic alopecia is characterized by progressive hair miniaturization where susceptible follicles produce increasingly fine and short hairs over successive growth cycles. In men, it typically causes temple recession and crown thinning, while women usually experience a widening part and reduced overall density on top of the scalp.

How soon after a stressful event does telogen effluvium shedding begin?

Shedding from telogen effluvium usually becomes noticeable two to four months after a significant physical or emotional stressor, such as major surgery, severe illness, childbirth, or substantial weight loss. This delayed onset often makes it challenging for patients to connect the shedding event to its original trigger.

Can a person experience telogen effluvium and androgenetic alopecia simultaneously?

Yes, an individual can have underlying androgenetic alopecia while also developing telogen effluvium. This overlap means that simply counting shed hairs is insufficient for diagnosis, as a patient might experience sudden heavy shedding on top of years of gradual, progressive volume loss.

Why is telogen effluvium lasting over six months considered unique?

Telogen effluvium that persists for more than six months is classified as chronic. While many cases of telogen effluvium are temporary and resolve as the underlying trigger is addressed, chronic forms show that temporary does not always mean a quick recovery or a uniform timeline.

Why is a hair transplant unsuitable as a primary treatment for telogen effluvium?

Transplanting additional follicles does not address the root cause of why existing hairs are shedding during telogen effluvium. Operating prematurely can waste a limited donor reserve on an area that is still changing, which is why investigating the underlying cause and allowing time for natural recovery is essential first.